Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate Cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 14, Issue 6, Pages 12496-12519
Publisher
MDPI AG
Online
2013-06-14
DOI
10.3390/ijms140612496
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Agents That Target Androgen Synthesis in Castration-Resistant Prostate Cancer
- (2013) Roberta Ferraldeschi et al. CANCER JOURNAL
- Androgen Receptor Antagonists in Castration-Resistant Prostate Cancer
- (2013) Dana Rathkopf et al. CANCER JOURNAL
- The Discovery of Novel Human Androgen Receptor Antagonist Chemotypes Using a Combined Pharmacophore Screening Procedure
- (2013) Arnout Voet et al. ChemMedChem
- Molecular Pathways: Inhibiting Steroid Biosynthesis in Prostate Cancer
- (2013) R. Ferraldeschi et al. CLINICAL CANCER RESEARCH
- Improved Therapeutic Targeting of the Androgen Receptor: Rational Drug Design Improves Survival in Castration-Resistant Prostate Cancer
- (2013) Ai Chiin Lim et al. CURRENT DRUG TARGETS
- Androgen Receptor Gene Rearrangements: New Perspectives on Prostate Cancer Progression
- (2013) Lucas J. Brand et al. CURRENT DRUG TARGETS
- In vitro model systems to study androgen receptor signaling in prostate cancer
- (2013) Natalie Sampson et al. ENDOCRINE-RELATED CANCER
- Enzalutamide for the treatment of prostate cancer
- (2013) Sumanta K Pal et al. EXPERT OPINION ON PHARMACOTHERAPY
- SAR Based Design of Nicotinamides as a Novel Class of Androgen Receptor Antagonists for Prostate Cancer
- (2013) Su Hui Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting the Binding Function 3 (BF3) Site of the Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzimidazole Derivatives
- (2013) Ravi Shashi Nayana Munuganti et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antitumor activity of a pyrrole-imidazole polyamide
- (2013) F. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treatment options in castration-resistant prostate cancer: Current therapies and emerging docetaxel-based regimens
- (2013) Fred Saad et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Relationship Between Body Mass Index and Serum Testosterone Concentration in Patients Receiving Luteinizing Hormone-releasing Hormone Agonist Therapy for Prostate Cancer
- (2013) Tim M. van der Sluis et al. UROLOGY
- Targeting the Adrenal Gland in Castration-Resistant Prostate Cancer: A Case for Orteronel, a Selective CYP-17 17,20-Lyase Inhibitor
- (2013) Hui Zhu et al. Current Oncology Reports
- Interplay Between Genomic Alterations and Androgen Receptor Signaling During Prostate Cancer Development and Progression
- (2013) Michael D. Nyquist et al. Hormones & Cancer
- ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
- (2012) N. J. Clegg et al. CANCER RESEARCH
- Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
- (2012) Y. Li et al. CANCER RESEARCH
- The androgen receptor gene mutations database: 2012 update
- (2012) Bruce Gottlieb et al. HUMAN MUTATION
- A New Trick of an Old Molecule: Androgen Receptor Splice Variants Taking the Stage?!
- (2012) Zhiyong Guo et al. International Journal of Biological Sciences
- 20(S)-protopanaxadiol-aglycone downregulation of the full-length and splice variants of androgen receptor
- (2012) Bo Cao et al. INTERNATIONAL JOURNAL OF CANCER
- A Competitive Inhibitor That Reduces Recruitment of Androgen Receptor to Androgen-responsive Genes
- (2012) Milu T. Cherian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure-based Virtual Screening and Identification of a Novel Androgen Receptor Antagonist
- (2012) Chin-Hee Song et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Stepwise androgen receptor dimerization
- (2012) M. E. van Royen et al. JOURNAL OF CELL SCIENCE
- Discovery of Diarylhydantoins as New Selective Androgen Receptor Modulators
- (2012) François Nique et al. JOURNAL OF MEDICINAL CHEMISTRY
- Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
- (2012) Karim Fizazi et al. LANCET ONCOLOGY
- Beyond the Ligand-Binding Pocket: Targeting Alternate Sites in Nuclear Receptors
- (2012) Laura Caboni et al. MEDICINAL RESEARCH REVIEWS
- Endocrine prevention and treatment of prostate cancer
- (2012) Teuvo L.J. Tammela MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The hinge region in androgen receptor control
- (2012) Liesbeth Clinckemalie et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Androgen action and metabolism in prostate cancer
- (2012) Sean M. Green et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Identification and Characterization of MEL-3, a Novel AR Antagonist That Suppresses Prostate Cancer Cell Growth
- (2012) Christine Helsen et al. MOLECULAR CANCER THERAPEUTICS
- In SilicoDiscovery of Androgen Receptor Antagonists with Activity in Castration Resistant Prostate Cancer
- (2012) Howard C. Shen et al. MOLECULAR ENDOCRINOLOGY
- Allosteric Conversation in the Androgen Receptor Ligand-Binding Domain Surfaces
- (2012) Solène Grosdidier et al. MOLECULAR ENDOCRINOLOGY
- Targeting the Androgen Receptor
- (2012) Terence W. Friedlander et al. UROLOGIC CLINICS OF NORTH AMERICA
- Biology of Castration-Recurrent Prostate Cancer
- (2012) Faris Azzouni et al. UROLOGIC CLINICS OF NORTH AMERICA
- Advanced Clinical States in Prostate Cancer
- (2012) Heather H. Cheng et al. UROLOGIC CLINICS OF NORTH AMERICA
- Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer
- (2012) Yohann Loriot et al. UROLOGIC CLINICS OF NORTH AMERICA
- Small Molecule Inhibitors Targeting the “Achilles' Heel” of Androgen Receptor Activity: Figure 1.
- (2011) Marianne D. Sadar CANCER RESEARCH
- Alternatively spliced androgen receptor variants
- (2011) Scott M Dehm et al. ENDOCRINE-RELATED CANCER
- Luteinizing hormone-releasing hormone receptor targeted agents for prostate cancer
- (2011) Stephen V Liu et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo
- (2011) Justin B. Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Niphatenones, Glycerol Ethers from the Sponge Niphates digitalis Block Androgen Receptor Transcriptional Activity in Prostate Cancer Cells: Structure Elucidation, Synthesis, and Biological Activity
- (2011) Labros G. Meimetis et al. JOURNAL OF MEDICINAL CHEMISTRY
- Unexpected Binding Orientation of Bulky-B-Ring Anti-Androgens and Implications for Future Drug Targets
- (2011) Charles B. Duke et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibitors of Androgen Receptor Activation Function-2 (AF2) Site Identified through Virtual Screening
- (2011) Peter Axerio-Cilies et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor through Virtual Screening.
- (2011) Nathan A. Lack et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel Therapeutic Strategies for Castration Resistant Prostate Cancer: Inhibition of Persistent Androgen Production and Androgen Receptor Mediated Signaling
- (2011) Arturo Molina et al. JOURNAL OF UROLOGY
- Putting the brakes on continued androgen receptor signaling in castration-resistant prostate cancer
- (2011) Andrew Eichholz et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Androgen receptor coregulators: Recruitment via the coactivator binding groove
- (2011) Dennis J. van de Wijngaart et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- A conserved surface on the ligand binding domain of nuclear receptors for allosteric control
- (2011) Víctor Buzón et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Intrinsic disorder in the androgen receptor: identification, characterisation and drugability
- (2011) Iain J. McEwan Molecular BioSystems
- Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer
- (2011) Kristin R. Lamont et al. MOLECULAR ENDOCRINOLOGY
- Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells
- (2011) J. T. De Leon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Advances in small molecule inhibitors of androgen receptor for the treatment of advanced prostate cancer
- (2011) Marianne D. Sadar WORLD JOURNAL OF UROLOGY
- Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor
- (2010) Raymond J. Andersen et al. CANCER CELL
- Identification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen Receptor
- (2010) X. Edward Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
- (2010) Shihua Sun et al. JOURNAL OF CLINICAL INVESTIGATION
- Structural Basis for Cyclic Py-Im Polyamide Allosteric Inhibition of Nuclear Receptor Binding
- (2010) David M. Chenoweth et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
- (2010) Howard I Scher et al. LANCET
- Evolution of steroid receptors from an estrogen-sensitive ancestral receptor
- (2010) Geeta N. Eick et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The Rules of DNA Recognition by the Androgen Receptor
- (2010) Sarah Denayer et al. MOLECULAR ENDOCRINOLOGY
- Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
- (2010) P. A. Watson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
- (2009) Z. Guo et al. CANCER RESEARCH
- Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial
- (2009) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Allosteric modulation of DNA by small molecules
- (2009) D. M. Chenoweth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance
- (2008) S. M. Dehm et al. CANCER RESEARCH
- Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth
- (2008) R. B. Montgomery et al. CANCER RESEARCH
- Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
- (2008) R. Hu et al. CANCER RESEARCH
- In vivo Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors
- (2008) R. Snoek et al. CLINICAL CANCER RESEARCH
- Characterization of Nuclear Import of the Domain-Specific Androgen Receptor in Association with the Importin α/β and Ran-Guanosine 5′-Triphosphate Systems
- (2008) Natsuko Kaku et al. ENDOCRINOLOGY
- Structural basis for the nuclear import of the human androgen receptor
- (2008) M. L. Cutress et al. JOURNAL OF CELL SCIENCE
- Consequences of poly-glutamine repeat length for the conformation and folding of the androgen receptor amino-terminal domain
- (2008) Philippa Davies et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- 17 -Hydroxylase/17,20 lyase inhibitor VN/124-1 inhibits growth of androgen-independent prostate cancer cells via induction of the endoplasmic reticulum stress response
- (2008) R. D. Bruno et al. MOLECULAR CANCER THERAPEUTICS
- Sintokamides A to E, Chlorinated Peptides from the SpongeDysideasp. that Inhibit Transactivation of the N-Terminus of the Androgen Receptor in Prostate Cancer Cells
- (2008) Marianne D. Sadar et al. ORGANIC LETTERS
- Androgen receptor variants and prostate cancer in humanized AR mice
- (2007) Diane M. Robins et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now